China, Sept. 18 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Diagnostic value of Trop2-targeted immuno-PET/CT in disease postoperative assessment of papillary thyroid carcinoma'. The following are the other relevant details related to the trial:
Registration Number: ChiCTR2600132793
Registration Time: 2026/09/18
Type: Diagnostic test
Primary Sponsor: jiangxi cancer hospital
To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=342848
Published by HT Digital Content Services with permission from Health Daily Digest....